Processing your payment...
Please do not close your browser.

Clinical Trial Supply and Logistic for Pharmaceutical Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Thermo Fisher Scientific Inc, Catalent Pharma Solutions, Almac Group

14 Apr, 2022 | 109 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Registering a CAGR of 8.25% over the forecast period, the market value of Clinical Trial Supply and Logistic for Pharmaceutical is expected to reach US$ 28,402.26 million in the year 2027.



Clinical Trial Supply and Logistic for Pharmaceutical Market Overview



A clinical trial is a phase of research in the medical sector that involves a trial of the end product to determine the drug's safety. To obtain results, each clinical experiment requires distinct and clean equipment. Clinical trial and logistic service providers help research institutes succeed by offering support and equipment for clinical studies. The service providers are also in charge of managing trial sites and contacting potential patients for drug testing. The primary factor driving the market's expansion is the rising number of diseases and difficulties, as well as the need to produce treatments to treat infected patients. 



The rising investment in drug research and the rise in drug research projects globally are two of the primary factors driving market expansion over the anticipated period. While the government funds the first medication research, pharmaceutical corporations or venture capitalists fund the later stages, specifically the clinical trial and subsequent stage research. Increasing disease complexity, as well as rising illness incidence and rising investment in the drug research industry, are expected to drive market expansion throughout the estimated period.



The report aspects discussed the profile of the top manufacturers of the global Clinical Trial Supply and Logistic for Pharmaceutical market. These aspects include financial status of major companies, trending advancements and entire market scenario. Growth of the report have examined Clinical Trial Supply and Logistic for Pharmaceutical Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.




Who are the Major Players in A Clinical Trial Supply and Logistic for Pharmaceutical Market?



Top Key Players in the Clinical Trial Supply and Logistic for Pharmaceutical Market have been identified through secondary research, and their market shares have been determined through primary and secondary research. The global Clinical Trial Supply and Logistic for Pharmaceutical Market is fragmented with a large number of small players operating worldwide. The companies referred to in the market research report include Thermo Fisher Scientific Inc.(NYSE: TMO), Catalent Pharma Solutions, Almac Group, Parexel International, UDG Healthcare, PCI Services, Marken, Klifo A/S., Walden Group, Bilcare Limited, Biocair and others.



Industry News and Updates:



PCI Pharma Service Launches Digital Platform for Supply Chain Management



October 1, 2020-- PCI Pharma Services, a drug development solutions company based in Philadelphia, PA, announced on Sept. 28, 2020 that it has launched pci | bridge, a digital platform that provides customers with real-time clinical and commercial supply chain data and insights. The platform makes inventory, production, distribution, and shipping data immediately accessible by integrating the platform with PCI’s other systems, making the data manageable from both sides. The platform also comes equipped with a document repository for the storage of electronic paperwork.



Almac Group Announces Almac ONE™ – A Unified Clinical Trial Supply Solution



6 March 2019 – Almac Group announces Almac ONE™ – providing the first unified Clinical Trial Supply solution. This solution redefines the Clinical Supply Chain experience, creating a responsive end-to-end process that enhances visibility and accuracy throughout the lifecycle of a clinical study. The drug development market continues to evolve significantly with common challenges such as expensive investigational products, limited inventory and globalization of clinical trials. One of the key challenges facing sponsors today is the disconnect that exists across the clinical supply chain with variable recruitment patterns and patient demand. This leads to disjointed and costly trials resulting infrequently missed milestones.



What are the major Applications, Types, and Regions for Clinical Trial Supply and Logistic for Pharmaceutical Market?



The market is segmented based on the type, applications, companies, and regions.



By Type, it is segmented into




  • Phase I

  • Phase II

  • Phase III



By Application, it is segmented into




  • Logistics & Distribution

  • Manufacturing and Packaging

  • Supply Chain Management

  • Other



Clinical Trial Supply and Logistic for Pharmaceutical Market Regional Analysis



The US healthcare industry is massive, with healthcare spending accounting for over 19.7% of US GDP in 2020. The US healthcare industry is massive, and is continuing to grow as the population swells. Many different types of companies and healthcare institutions work together to provide patient satisfaction and a better quality of care. It is expected that the North America and Europe clinical trial and the logistic market will dominate the global industry owing to the larger concentration of pharmaceutical research industries. The Asia Pacific market is forecasted to grow at a significant rate.




  • North America


    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East & Africa

    • Latin America





The Clinical Trial Supply and Logistic for Pharmaceutical Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Clinical Trial Supply and Logistic for Pharmaceutical Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.



What is our Clinical Trial Supply and Logistic for Pharmaceutical Market report scope?



Scope of the Report covers Clinical Trial Supply and Logistic for Pharmaceutical Market with detailed analysis of the overall scenario for the market. It also highlights the business participants environment in the global marketplace. This report also provides an overview of leading companies covering the latest successful marketing strategies, market contributions, current and historical background and latest market happenings to help key organizations to grow and generate larger profits. Business players will greatly benefit from this Clinical Trial Supply and Logistic for Pharmaceutical Market analysis report as it has vital details to provide about regional markets, expected opportunities for the prediction time period 2022-2027. Growth between segments is used to understand the different growth factors that are expected to dominate the market as a whole and to develop strategies to differentiate between key applications and target markets. It further reveals how worldwide market is working through efficient information graphics.



























































Report Attributes



Report Details



Report Title



Clinical Trial Supply and Logistic for Pharmaceutical Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Thermo Fisher Scientific Inc.(NYSE: TMO), Catalent Pharma Solutions, Almac Group, Parexel International



Forecast Period 2022 to 2027 CAGR



CAGR of 8.25% over the forecast period (2022-2027)



By Type




  • Phase I

  • Phase II

  • Phase III



By Application




  • Logistics & Distribution

  • Manufacturing and Packaging

  • Supply Chain Management

  • Other



By Companies



Thermo Fisher Scientific Inc.(NYSE: TMO), Catalent Pharma Solutions, Almac Group, Parexel International, UDG Healthcare, PCI Services, Marken, Klifo A/S., Walden Group, Bilcare Limited, Biocair



Regions Covered




  • North America

  • Europe

  • Asia-Pacific

  • Rest of the World



Countries Covered




  • US

  • Canada

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Europe

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific

  • Middle East & Africa

  • Latin America



Base Year



2022



Historical Year



2017 to 2021



Forecast Year



2022 to 2027



Number of Pages



109



Customization Available



Yes, the report can be customized as per your needs




 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



Key Takeaways from this Clinical Trial Supply and Logistic for Pharmaceutical Report




  • Evaluate Clinical Trial Supply and Logistic for Pharmaceutical market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.

  • Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.

  • Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.

  • Analyze the sales and distribution channels across geographies to enhance top-line revenues.

  • Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.

  • Get a quick outlook on the Clinical Trial Supply and Logistic for Pharmaceutical market entropy - M&A's, deals, partnerships, product launches of all key players for the past 5 years.

  • Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.



Frequently Asked Questions



What is the study period of this market?



The Clinical Trial Supply and Logistic for Pharmaceutical Market is studied from 2017 - 2027.



What is the growth rate of Clinical Trial Supply and Logistic for Pharmaceutical Market?



The Clinical Trial Supply and Logistic for Pharmaceutical Market is growing at a CAGR of 8.25% over the next 5 years.



Who are the key players in Clinical Trial Supply and Logistic for Pharmaceutical Market?



Thermo Fisher Scientific Inc.(NYSE: TMO), Catalent Pharma Solutions, Almac Group, Parexel International, UDG Healthcare, PCI Services, Marken, Klifo A/S., Walden Group, Bilcare Limited, Biocair



What regions does this Clinical Trial Supply and Logistic for Pharmaceutical Market report covers?



North America (the United States, Canada, and Mexico)



Europe (Germany, France, UK, Russia, and Italy)



Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)



South America (Brazil, Argentina, Colombia, etc.)



The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)



What are the significant types of Clinical Trial Supply and Logistic for Pharmaceutical Market?



Phase I, Phase II, Phase III



What are the major end-use applications of Clinical Trial Supply and Logistic for Pharmaceutical Market?



Logistics & Distribution, Manufacturing and Packaging, Supply Chain Management, Other



All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.


  1. INTRODUCTION

    1. MARKET DEFINATION

    2. MARKET DYNAMICS

    3. MARKET SEGMENTATION

    4. REPORT TIMLINES

    5. KEY STAKEHOLDERS



  2. RESEARCH METHODOLOGY

    1. DATA MINING

      1. SECONDARY RESEARCH

      2. PRIMARY RESEARCH

      3. SUBJECT MATTER EXPERT ADVICE



    2. QUALITY CHECK

    3. FINAL REVIEW

      1. DATA TRIANGULATION

      2. BOTTOM-UP APPROACH

      3. TOP-DOWN APPROACH



    4. RESEARCH FLOW



  3. EXECUTIVE SUMMARY

    1. INTRODUCTION

    2. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTIC FOR PHARMACEUTICAL MARKET BY TYPE

    3. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTIC FOR PHARMACEUTICAL MARKET BY APPLICTAION



  4. MARKET DYNAMICS

    1. DRIVERS

      1. INCREASING DEMAND FOR CLINICAL TRIAL SUPPLY AND LOGISTIC FOR PHARMACEUTICAL



    2. RESTRAINTS

      1. STRINGENT ENVIRONMENTAL REGUALTIONS

      2. HIGH COST ON MATERIALS



    3. OPPORTUNITIES

      1. CLINICAL TRIAL SUPPLY AND LOGISTIC FOR PHARMACEUTICAL GROWTH

      2. APPLICATION OF CLINICAL TRIAL SUPPLY AND LOGISTIC FOR PHARMACEUTICAL



    4. IMPACT OF COVID 19



  5. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTIC FOR PHARMACEUTICAL MARKET, BY TYPE

    1. INTRODUCTION

    2. PHASE I

    3. PHASE II

    4. PHASE III     



  6. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTIC FOR PHARMACEUTICAL MARKET, BY APPLICATION

    1. INTRODUCTION

    2. LOGISTICS & DISTRIBUTION

    3. MANUFACTURING AND PACKAGING

    4. SUPPLY CHAIN MANAGEMENT

    5. OTHER



  7. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTIC FOR PHARMACEUTICAL MARKET, BY REGION

    1. NORTH AMERICA

      1. US

      2. CANADA

      3. MEXICO



    2. EUROPE

      1. GERMANY

      2. FRANCE

      3. UK

      4. ITALY

      5. RUSSIA

      6. REST OF EUROPE



    3. APAC

      1. CHINA

      2. SOUTH KOREA

      3. JAPAN

      4. INDIA

      5. AUSTRALIA

      6. ASEAN

      7. REST OF APAC



    4. MIDDLE EAST & AFRICA

      1. SAUDI ARABIA

      2. UAE

      3. SOUTH AFRICA

      4. TURKEY

      5. REST OF MEA



    5. SOUTH AMERICA

      1. BRAZIL

      2. REST OF MEA

      3. ARGENTINA

      4. REST OF SOUTH AMERICA





  8. COMPETITIVE LANDSCAPE

    1. MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,

    2. AND AGREEMENTS

      1. KEY DEVELOPMENT



    3. MARKET SHARE (%) **/RANKING ANALYSIS

    4. STRATEGIES ADOPTED BY LEADING PLAYERS



  9. COMPANY PROFILES

    1. BUSINESS OVERVIEW

    2. COMPANY SNAPSHOT

    3. PRODUCT BENCHMARKING

    4. STRATEGIC INITIATIVES

      1. THERMO FISHER SCIENTIFIC

      2. CATALENT PHARMA SOLUTIONS

      3. ALMAC GROUP

      4. PAREXEL INTERNATIONAL

      5. UDG HEALTHCARE

      6. PCI SERVICES

      7. MARKEN

      8. KLIFO A/S.

      9. WALDEN GROUP

      10. BILCARE LIMITED

      11. BIOCAIR





SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Merck
  • IBM
  • Dow
  • Henkel
  • AirBus
  • Cummins
  • Intel
  • Sony
  • 9
  • 3M